Cingulate completes $25M IPO, becomes KC area's newest public company
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- CING
- CINGW
A Westwood company developing new pharmaceutical treatments raised roughly $25 million for the effort through an initial public stock offering on Friday. Cingulate Inc. sold more than 4.1 million shares, packaged with warrants, in its IPO. Cingulate is developing drugs using proprietary Precision Timed Release technology to address problems caused by frequency of dosing or declines in the drug level in patients between doses. The company has three drugs in its development pipeline — two for treatment of attention-deficit/hyperactivity disorder (ADHD) and one for anxiety.